Clinical Trial Update: Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating pazopanib hydrochloride in combination with bevacizumab for previously untreated metastatic renal cell carcinoma (clear ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Votrient (Pazopanib)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING